Foorquan Hashmi: Our collective commitment is embodied in the belief that ‘Cancer doesn’t take a day off: neither do we’
Foorquan Hashmi, Assistant Managing Editor at
“That’s amazing news!
Everyone at the FDA gave it a thumbs up, which is super exciting for folks with multiple myeloma.
OncoDaily is making significant strides in raising global awareness through its timely news updates. I feel privileged to be part of the OncoDaily team, led by the visionary Chief, Dr Gevorg Tamamyan. Our collective commitment is embodied in the belief that “Cancer doesn’t take a day off: neither do we.’
I strongly encourage both medical professionals and the global community to subscribe to the Oncodaily newsletter and follow its social media channels. This ensures that everyone stays up-to-date and no one is left behind.
OncoDaily newsletter
Twitter
Facebook”
Quoting OncoDaily‘s post:
“FDA ODAC voted 12-0. Historic victory in multiple myeloma
The OncoDaily Team provided a summary of important information and opinions from key opinion leaders about this significant milestone.”
Read further.
Source: Foorquan Hashmi/LinkedIn and OncoDaily/LinkedIn
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.